Kartini Hasballah Selected Research

Protein-Tyrosine Kinases (Tyrosine Kinase)

1/2022

Molecular docking investigation of calotropone as a potential natural therapeutic agent against pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kartini Hasballah Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 08/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 08/2021
1	Hypertension (High Blood Pressure) 04/2024
1	Atopic Dermatitis (Atopic Eczema) 11/2023

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2021
1	acetone hydrazoneIBA 04/2024
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 11/2023
1	Immunoglobulin E (IgE)IBA 11/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	calotroponeIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	benzimidazoleIBA 01/2022
1	TransferasesIBA 01/2022
1	DisintegrinsIBA 01/2022
1	isoliquiritigenin (GU 17)IBA 08/2021

Therapy/Procedure

1	Therapeutics 08/2021